About this item:

432 Views | 881 Downloads

Author Notes:

Address correspondence to: Deborah S. Yokoe, MD, MPH, 181 Longwood Avenue, Boston, MA 02115 (dyokoe@partners.org).

We thank the many individuals who, on behalf of the partnering and endorsing organizations, reviewed the Compendium articles and submitted comments.

We appreciate their work and careful consideration to ensure the quality of the 2014 Compendium updates.

Potential conflicts of interest. Authors report the following. E.R.D.—advisor/consultant: Sanofi Pasteur, Merck, Pfizer; research grants/contracts: Sanofi Pasteur, ViroPharma, Optimer, Merck, Rebiotix. D.N.G.—advisor/consultant: Merck, Cubist, Novartis, Cangene, Actelion, ViroPharma, Rebiotix, Sanofi Pasteur; honoraria: Robert Michael; patent/license (no royalties): ViroPharma; research grant/contract: GOJO Industries. J.H.—research grant/contract: 3M. K.S.K.—grant support and advisor/consultant: Sage Products. M.K.—honoraria: Premier Healthcare Alliance. E.L.—research grants/contract: Cangene Corporation, antibody responses to C. difficile–associated diarrhea. J.M.—honorarium: Gilead Sciences, Switzerland. L.A.M.—advisor/consultant: ICU Medical, Fresenius Medical Care, Bard Access Systems, Marvao Medical Devices, CareFusion, 3M Healthcare, Catheter Connections, Semprus Biosciences, Sharklet Technologies. L.N.—advisor/consultant: Cerena, Johnson & Johnson. K.B.—honorarium: Pfizer; research grants/contracts: Pfizer, Med-Immune, Novarti. N.F.—financial relationships/income (stocks/bonds): Pfizer, GE. T.M.P.—research grant/contract: Merck. D.S.Y., D.J.A., S.M.B., D.C., K.D.E., C.S., D.P.C., K.C., E.H., J.P., K.P., M.V.A., T.W., R.A.W., N.F., and L.L.M. have no conflicts to disclose.

Management plans, where authors indicated the method by which the section members and they would manage their disclosure(s) if applicable, are posted here: http://www.shea-online.org/PriorityTopics/CompendiumofStrategiestoPreventHAIs.aspx


Research Funding:

Support for this Compendium was provided by the Society for Healthcare Epidemiology of America.


  • Science & Technology
  • Life Sciences & Biomedicine
  • Public, Environmental & Occupational Health
  • Infectious Diseases

A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates

Show all authors Show less authors


Journal Title:

Infection Control and Hospital Epidemiology


Volume 35, Number 8


, Pages 967-977

Type of Work:

Article | Post-print: After Peer Review


Since the publication of "A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals" in 2008, prevention of healthcare-associated infections (HAIs) has become a national priority. Despite improvements, preventable HAIs continue to occur. The 2014 updates to the Compendium were created to provide acute care hospitals with up-to-date, practical, expert guidance to assist in prioritizing and implementing their HAI prevention efforts. They are the product of a highly collaborative effort led by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), the American Hospital Association (AHA), the Association for Professionals in Infection Control and Epidemiology (APIC), and The Joint Commission, with major contributions from representatives of a number of organizations and societies with content expertise, including the Centers for Disease Control and Prevention (CDC), the Institute for Healthcare Improvement (IHI), the Pediatric Infectious Diseases Society (PIDS), the Society for Critical Care Medicine (SCCM), the Society for Hospital Medicine (SHM), and the Surgical Infection Society (SIS).

Copyright information:

© 2014 by The Society for Healthcare Epidemiology of America. All rights reserved.

Export to EndNote